Yeji
PDUFAoutcome: unknownconf 0.99

orladeyo (berotralstat) — PDUFA

$BCRX · BIOCRYST PHARMACEUTICALS INC · Hereditary angioedema (HAE) in pediatric patients aged 2 to 11 years
Event date
September 12, 2025
267 days ago
Sponsor runway
12 mo
$238.4M liquid

Evidence

The FDA also granted priority review of the application, with a Prescription Drug User Fee Act ("PDUFA") target action date of September 12, 2025.
Source: 8-K filed 2025-05-14View on EDGAR ↗0001171843-25-003152

Comparable historical pdufas· last 5 years · same event type

60% hit rate (3/5)
TickerDrugDateOutcome
$RCKTkresladi2026-03-28success
$RYTMimcivree2026-03-20success
$CYTKaficamten2025-12-26unknown
$ALDXreproxalap2025-12-16unknown
$BCRXorladeyo2025-12-12success
$OMERnarsoplimab2025-09-25unknown
$ETONet-4002025-05-28unknown
$ALDXreproxalap2025-04-02failure
$IONSolezarsen2024-12-19unknown
$RCKTkresladi2024-06-30failure

Recent insider activity· ±90 days

7 insiders · 0 buys · 5 sells
Sell10b5-1
2025-12-03
Barnes Alane P
Chief Legal Officer
19,770 @ $7.65$151K
Sell10b5-1
2025-12-02
Barnes Alane P
Chief Legal Officer
50,906 @ $7.21$367K
Sell10b5-1
2025-12-01
Barnes Alane P
Chief Legal Officer
91,004 @ $7.10$647K
Exercise10b5-1
2025-12-01
Barnes Alane P
Chief Legal Officer
91,004 @ $3.22$293K
Grant
2025-11-28
McKee Amy E
Director
783 @ $7.18$6K
Grant
2025-11-28
Frank Steven
Director
1,566 @ $7.18$11K
Grant
2025-11-28
MILANO VINCENT
Director
783 @ $7.18$6K
Sell10b5-1
2025-11-13
SANDERS MACHELLE
Director
9,600 @ $7.14$69K
Grant
2025-08-29
Frank Steven
Director
1,353 @ $8.31$11K
Grant
2025-08-29
McKee Amy E
Director
676 @ $8.31$6K
Grant
2025-08-29
MILANO VINCENT
Director
676 @ $8.31$6K
Exercise
2025-08-13
HEGGIE THERESA
Director
30,000 @ $2.91$87K
Exercise
2025-08-13
HEGGIE THERESA
Director
40,000 @ $5.41$216K
Sell
2025-08-13
HEGGIE THERESA
Director
70,000 @ $8.51$596K
Grant
2025-07-24
Ghias Babar
Chief Financial Officer
147,000 @
Grant
2025-07-24
Ghias Babar
Chief Financial Officer
305,000 @